In vivo Genome Editing Therapeutic Approaches for Neurological Disorders: Where Are We in the Translational Pipeline?
出版年份 2021 全文链接
标题
In vivo Genome Editing Therapeutic Approaches for Neurological Disorders: Where Are We in the Translational Pipeline?
作者
关键词
-
出版物
Frontiers in Neuroscience
Volume 15, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-02-21
DOI
10.3389/fnins.2021.632522
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy
- (2020) Gaia Colasante et al. BRAIN
- Treatment of a Mouse Model of ALS by In Vivo Base Editing
- (2020) Colin K.W. Lim et al. MOLECULAR THERAPY
- In Vitro CRISPR/Cas9-Directed Gene Editing to Model LRRK2 G2019S Parkinson’s Disease in Common Marmosets
- (2020) Scott C. Vermilyea et al. Scientific Reports
- CRISPR deletion of the C9ORF72 promoter in ALS/FTD patient motor neurons abolishes production of dipeptide repeat proteins and rescues neurodegeneration
- (2020) Gopinath Krishnan et al. ACTA NEUROPATHOLOGICA
- Gene editing and CRISPR in the clinic: current and future perspectives
- (2020) Matthew P. Hirakawa et al. BIOSCIENCE REPORTS
- CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
- (2020) Dan Wang et al. CELL
- Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice
- (2020) Haibo Zhou et al. CELL
- Reactivation of FMR1 gene expression is a promising strategy for fragile X syndrome therapy
- (2020) Ekaterina M. Shitik et al. GENE THERAPY
- Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
- (2020) Andrew V. Anzalone et al. NATURE BIOTECHNOLOGY
- CRISPR/dCas9-based Scn1a gene activation in inhibitory neurons ameliorates epileptic and behavioral phenotypes of Dravet syndrome model mice
- (2020) Tetsushi Yamagata et al. NEUROBIOLOGY OF DISEASE
- Recent advances in gene therapy for neurodevelopmental disorders with epilepsy
- (2020) Thomas J. Turner et al. JOURNAL OF NEUROCHEMISTRY
- Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA
- (2020) Justin M. Wolter et al. NATURE
- Modulating gene regulation to treat genetic disorders
- (2020) Navneet Matharu et al. NATURE REVIEWS DRUG DISCOVERY
- Genome Editing for CNS Disorders
- (2020) Fábio Duarte et al. Frontiers in Neuroscience
- In vivo neuronal gene editing via CRISPR–Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer’s disease
- (2019) Hanseul Park et al. NATURE NEUROSCIENCE
- Editing the Central Nervous System Through CRISPR/Cas9 Systems
- (2019) Agustin Cota-Coronado et al. Frontiers in Molecular Neuroscience
- dCas9-based Scn1a gene activation restores inhibitory interneuron excitability and attenuates seizures in Dravet syndrome mice
- (2019) Gaia Colasante et al. MOLECULAR THERAPY
- Search-and-replace genome editing without double-strand breaks or donor DNA
- (2019) Andrew V. Anzalone et al. NATURE
- Advances in genome editing through control of DNA repair pathways
- (2019) Charles D. Yeh et al. NATURE CELL BIOLOGY
- CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease
- (2018) Bence György et al. Molecular Therapy-Nucleic Acids
- Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD
- (2018) Boris Kantor et al. MOLECULAR THERAPY
- Cas9 immunity creates challenges for CRISPR gene editing therapies
- (2018) Julie M. Crudele et al. Nature Communications
- CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency
- (2018) Navneet Matharu et al. SCIENCE
- CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington’s disease
- (2017) Su Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
- (2017) Nicole M. Gaudelli et al. NATURE
- Virus-Mediated Genome Editing via Homology-Directed Repair in Mitotic and Postmitotic Cells in Mammalian Brain
- (2017) Jun Nishiyama et al. NEURON
- Targeted DNA methylation in human cells using engineered dCas9-methyltransferases
- (2017) Tina Xiong et al. Scientific Reports
- Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing
- (2016) Angelo Amabile et al. CELL
- Editing DNA Methylation in the Mammalian Genome
- (2016) X. Shawn Liu et al. CELL
- In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
- (2016) Keiichiro Suzuki et al. NATURE
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- Targeted DNA demethylation in vivo using dCas9–peptide repeat and scFv–TET1 catalytic domain fusions
- (2016) Sumiyo Morita et al. NATURE BIOTECHNOLOGY
- Repurposing the CRISPR-Cas9 system for targeted DNA methylation
- (2016) Aleksandar Vojta et al. NUCLEIC ACIDS RESEARCH
- Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
- (2016) K. Nishida et al. SCIENCE
- Reprogrammable CRISPR/Cas9-based system for inducing site-specific DNA methylation
- (2016) James I. McDonald et al. Biology Open
- A CRISPR-based approach for targeted DNA demethylation
- (2016) Xingxing Xu et al. Cell Discovery
- Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome
- (2016) Nina Xie et al. PLoS One
- Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
- (2015) Silvana Konermann et al. NATURE
- Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers
- (2015) Isaac B Hilton et al. NATURE BIOTECHNOLOGY
- Highly efficient Cas9-mediated transcriptional programming
- (2015) Alejandro Chavez et al. NATURE METHODS
- Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements
- (2015) Pratiksha I Thakore et al. NATURE METHODS
- Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons
- (2015) Chul-Yong Park et al. Cell Reports
- Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
- (2015) Xiao-Hui Zhang et al. Molecular Therapy-Nucleic Acids
- Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
- (2014) Steven Lin et al. eLife
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
- (2013) Lei S. Qi et al. CELL
- CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering
- (2013) Prashant Mali et al. NATURE BIOTECHNOLOGY
- RNA-guided gene activation by CRISPR-Cas9–based transcription factors
- (2013) Pablo Perez-Pinera et al. NATURE METHODS
- Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription
- (2011) Feng Zhang et al. NATURE BIOTECHNOLOGY
- Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes
- (2011) Ting Li et al. NUCLEIC ACIDS RESEARCH
- A TALE nuclease architecture for efficient genome editing
- (2010) Jeffrey C Miller et al. NATURE BIOTECHNOLOGY
- Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
- (2009) J. Boch et al. SCIENCE
- A Simple Cipher Governs DNA Recognition by TAL Effectors
- (2009) M. J. Moscou et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search